These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35420733)

  • 41. Generalized pustular psoriasis rapidly and successfully treated with ixekizumab in a Caucasian patient.
    Megna M; Abategiovanni L; Annunziata A; Torta G; Peduto T; Fabbrocini G; Lauro W
    Dermatol Ther; 2022 May; 35(5):e15382. PubMed ID: 35170168
    [No Abstract]   [Full Text] [Related]  

  • 42. Generalized pustular psoriasis recurring during pregnancy and lactation successfully treated with ixekizumab.
    Huang D; Liu T; Li J; Lu Y; Ma H
    Dermatol Ther; 2022 Dec; 35(12):e15878. PubMed ID: 36181408
    [No Abstract]   [Full Text] [Related]  

  • 43. Secukinumab for Acrodermatitis Continua of Hallopeau.
    Muggli D; Maul JT; Anzengruber F; Fopp MW; Navarini AA
    JAMA Dermatol; 2017 Apr; 153(4):336-337. PubMed ID: 28122071
    [No Abstract]   [Full Text] [Related]  

  • 44. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis?
    Sahin MT; Oztürkcan S; Türel A; Kandiloğlu AR
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):236-8. PubMed ID: 12705767
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
    García C; Arellano J; Vera V; Corredoira Y
    Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.
    Milani-Nejad N; Kaffenberger J
    J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
    Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E
    SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
    Puig L; Barco D; Vilarrasa E; Alomar A
    Dermatology; 2010; 220(2):154-8. PubMed ID: 20110631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy.
    Kiszewski AE; De Villa D; Scheibel I; Ricachnevsky N
    Pediatr Dermatol; 2009; 26(1):105-6. PubMed ID: 19250426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ixekizumab rapidly improves inflammatory markers in patients with generalized pustular psoriasis.
    Ito M; Kamata M; Uchida H; Egawa S; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Tada Y
    Br J Dermatol; 2022 Nov; 187(5):793-795. PubMed ID: 35661135
    [No Abstract]   [Full Text] [Related]  

  • 51. Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.
    Lanna C; Cesaroni GM; Mazzilli S; Lozzi F; Palumbo V; Diluvio L; Bianchi L; Campione E
    Dermatol Ther; 2019 Jul; 32(4):e12946. PubMed ID: 31025500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [About Acrodermatitis continua suppurativa Hallopeau inversa].
    KEINING E; JUNG-GRIMM H
    Dermatol Wochenschr; 1957 Aug; 136(34):900-9. PubMed ID: 13473415
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patients.
    Kromer C; Loewe E; Schaarschmidt ML; Pinter A; Gerdes S; Celis D; Poortinga S; Wilsmann-Theis D; Mössner R
    J Dermatol; 2020 Sep; 47(9):989-997. PubMed ID: 32632983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refractory acrodermatitis continua of Hallopeau successfully treated with oral alitretinoin.
    Park MY; Shim WH; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
    J Dermatol; 2018 Mar; 45(3):367-368. PubMed ID: 28432697
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin.
    Tobin AM; Kirby B
    Br J Dermatol; 2005 Aug; 153(2):445-6. PubMed ID: 16086767
    [No Abstract]   [Full Text] [Related]  

  • 56. Successful treatment of secukinumab-resistant palmoplantar pustulosis by Dupilumab: A case report.
    Zheng YX; Zheng M; Cai SQ
    Dermatol Ther; 2022 Nov; 35(11):e15781. PubMed ID: 35986706
    [No Abstract]   [Full Text] [Related]  

  • 57. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A.
    Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ
    Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497
    [No Abstract]   [Full Text] [Related]  

  • 58. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study.
    Ruan SF; Zhang LL; Liu Z; Lin TT; Wang HQ; Xu QY; Xiang N; Cheng B; Liu T; Ha HY; Gong T; Ji C
    J Am Acad Dermatol; 2023 Jan; 88(1):243-246. PubMed ID: 35588923
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pemphigus, Dermatitis herpetiformis, Impetigo herpetiformis, Acrodermatitis Hallopeau].
    MAIRE M
    Dermatologica; 1949; 98(3):193-6. PubMed ID: 18145566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.